Summary & Overview
HCPCS G9574: Six-Month Assessment for Depression Remission
HCPCS Level II code G9574 denotes a six-month treatment outcome assessment for adults (age 18+) diagnosed with major depression or dysthymia who have not achieved remission. The code is used when a six-month (+/-60 days) PHQ-9 or PHQ-9M indicates a score of five or higher, or when the instrument was not assessed, signaling incomplete or inadequate treatment response. This code matters nationally as payers and providers increasingly track longitudinal depression outcomes to monitor care quality and value-based performance.
Key payers addressed include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise explanation of the code's clinical intent, the typical ambulatory settings where it is used, and the types of analyses and benchmarks commonly associated with six-month depression outcome measures. The publication outlines how G9574 fits into depression monitoring workflows, highlights payer coverage relevance, and identifies the operational contexts—such as outpatient behavioral health and primary care—where the code is most applicable. Data not provided in the input (for example, specific ICD-10 pairings or taxonomy details) are noted as unavailable.
Billing Code Overview
HCPCS Level II code G9574 applies to adult patients age 18 and older with major depression or dysthymia who have not reached remission at six months, as demonstrated by a six month (+/-60 days) PHQ-9 or PHQ-9M score of less than five; alternatively, the PHQ-9 or PHQ-9M score was not assessed or is greater than or equal to five. This code captures a clinical assessment point focused on treatment response at six months for depressive disorders.
-
Service type: Mental health outcome assessment related to depression treatment at six months
-
Typical site of service: Outpatient behavioral health clinics, primary care offices, or other ambulatory settings where PHQ-9 or PHQ-9M monitoring is performed
Data not available in the input.
Clinical & Coding Specifications
Clinical Context
An adult patient, age 18 or older, with a diagnosed major depressive disorder or dysthymia presents for routine follow-up at six months after initiation of treatment. The clinic uses the Patient Health Questionnaire-9 (PHQ-9 or PHQ-9M) to assess symptom severity and remission status. At the six-month visit (allowable window ±60 days) the PHQ-9 score is obtained and documented. The billing code G9574 is applied when the patient has not reached remission by six months, defined as a PHQ-9 or PHQ-9M score of five or greater, or when the PHQ-9/PHQ-9M was not administered or not documented in the allowable window.
A typical clinical workflow:
-
Initial diagnosis and treatment planning for major depressive disorder or dysthymia, with baseline
PHQ-9. -
Ongoing treatment (psychotherapy, pharmacotherapy, care management) with periodic outcome measurement.
-
At approximately six months after treatment initiation (±60 days), clinician or behavioral health staff administers and scores the
PHQ-9/PHQ-9Mand documents results in the medical record.